Evidence map›Paper›PMID 34984719›Full record

ArticleAnnals of neurology2022

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse.

Kyla A McKay, Sahl K Bedri, Ali Manouchehrinia, Leszek Stawiarz, Tomas Olsson, Jan Hillert, Katharina Fink

Open access · hybridAbstract read
In one paragraph

Article in Annals of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Plateau of practice effects and noise with repeat SDMT testing in multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2025
    Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kyla A McKayDepartment of Clinical Neuroscience, Neuro Division, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9081-1522
Sahl K BedriDepartment of Clinical Neuroscience, Neuro Division, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-7750-5723
Ali ManouchehriniaDepartment of Clinical Neuroscience, Neuro Division, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-4857-5762
Leszek StawiarzDepartment of Clinical Neuroscience, Neuro Division, Karolinska Institutet, Stockholm, Sweden.
Tomas OlssonDepartment of Clinical Neuroscience, Neuro Division, Karolinska Institutet, Stockholm, Sweden.
Jan HillertDepartment of Clinical Neuroscience, Neuro Division, Karolinska Institutet, Stockholm, Sweden.
Katharina FinkDepartment of Clinical Neuroscience, Neuro Division, Karolinska Institutet, Stockholm, Sweden.
Karolinska University Hospital · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe purpose of this study was to explore the longitudinal relationship between multiple sclerosis (MS) relapses and information processing efficiency among persons with relapsing-remitting MS.

methodsWe conducted a Swedish nationwide cohort study of persons with incident relapsing-remitting MS (2001-2019). Relapse information and symbol digit modalities test (SDMT) scores were obtained from the Swedish MS Registry. Follow-up was categorized into 2 periods based on relapse status: "relapse" (90 days pre-relapse to 730 days post-relapse, subdivided into 10 periods) and "remission." Linear mixed models compared SDMT scores during the relapse periods to SDMT scores recorded during remission (reference) with results reported as β-coefficients and 95% confidence intervals (CIs), adjusted for age, sex, SDMT type (written vs oral), time-varying, disease-modifying therapy exposure and sequence of SDMT.

resultsOver a mean (SD) follow-up of 10.7 (4.3) years, 31,529 distinct SDMTs were recorded among 3,877 persons with MS. There was a significant decline in information processing efficiency that lasted from 30 days pre-relapse up to 550 days post-relapse, with the largest decline occurring 0 to 30 days post-relapse (β-coefficient: -4.00 (95% CI = -4.61 to -3.39), relative to the period of remission.

interpretationWe found evidence of cognitive change up to 1 month prior to relapse onset. The reduction in SDMT lasted 1.5 years and was clinically significant up to 3 months post-relapse. These results suggest that the effects of a relapse on cognition are longer than previously thought and highlight the importance of reducing relapse rates as a potential means of preserving cognitive function. ANN NEUROL 2022;91:417-423.

Indexed as

AdultCognitionFemaleFollow-Up StudiesHumansMaleMiddle AgedMultiple Sclerosis, Relapsing-RemittingNeuropsychological TestsReaction TimeRecurrenceRegistriesYoung Adult

Identifiers

PMID34984719
PMCPMC9303402
OpenAlexW4205310293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.